Logo image of PTP.DE

PENTIXAPHARM HOLDING AG (PTP.DE) Stock Fundamental Analysis

FRA:PTP - Deutsche Boerse Ag - DE000A40AEG0 - Common Stock - Currency: EUR

2.29  -0.18 (-7.29%)

Fundamental Rating

3

Overall PTP gets a fundamental rating of 3 out of 10. We evaluated PTP against 59 industry peers in the Health Care Equipment & Supplies industry. PTP has a great financial health rating, but its profitability evaluates not so good. PTP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PTP has reported negative net income.
PTP.DE Yearly Net Income VS EBIT VS OCF VS FCFPTP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 0 5M -5M -10M

1.2 Ratios

With a Return On Assets value of -23.13%, PTP is not doing good in the industry: 71.19% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -28.29%, PTP is doing worse than 67.80% of the companies in the same industry.
PTP has a better Return On Invested Capital (11.61%) than 88.14% of its industry peers.
Industry RankSector Rank
ROA -23.13%
ROE -28.29%
ROIC 11.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTP.DE Yearly ROA, ROE, ROICPTP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 0 10 -10 -20

1.3 Margins

PTP's Operating Margin of 119.05% is amongst the best of the industry. PTP outperforms 100.00% of its industry peers.
PTP does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 119.05%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTP.DE Yearly Profit, Operating, Gross MarginsPTP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024 0 100 -100

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PTP is still creating some value.
There is no outstanding debt for PTP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PTP.DE Yearly Shares OutstandingPTP.DE Yearly Shares OutstandingYearly Shares Outstanding 2024 5M 10M 15M 20M
PTP.DE Yearly Total Debt VS Total AssetsPTP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 20M 40M 60M

2.2 Solvency

PTP has an Altman-Z score of 5.05. This indicates that PTP is financially healthy and has little risk of bankruptcy at the moment.
PTP's Altman-Z score of 5.05 is amongst the best of the industry. PTP outperforms 83.05% of its industry peers.
There is no outstanding debt for PTP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACC1.62
WACC7.15%
PTP.DE Yearly LT Debt VS Equity VS FCFPTP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 0 10M 20M 30M 40M

2.3 Liquidity

PTP has a Current Ratio of 3.14. This indicates that PTP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.14, PTP is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
A Quick Ratio of 3.14 indicates that PTP has no problem at all paying its short term obligations.
PTP has a better Quick ratio (3.14) than 88.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.14
PTP.DE Yearly Current Assets VS Current LiabilitesPTP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 10M 20M 30M

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTP.DE Yearly Revenue VS EstimatesPTP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2M 4M 6M

1

4. Valuation

4.1 Price/Earnings Ratio

PTP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTP.DE Price Earnings VS Forward Price EarningsPTP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PTP is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.62
PTP.DE Per share dataPTP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PTP!.
Industry RankSector Rank
Dividend Yield N/A

PENTIXAPHARM HOLDING AG

FRA:PTP (6/20/2025, 5:25:02 PM)

2.29

-0.18 (-7.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.79M
Analysts80
Price Target11.95 (421.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.33
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB 5.47
EV/EBITDA 1.62
EPS(TTM)-0.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.27
BVpS1.83
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.13%
ROE -28.29%
ROCE 16.49%
ROIC 11.61%
ROICexc 17.94%
ROICexgc N/A
OM 119.05%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 3.14
Altman-Z 5.05
F-ScoreN/A
WACC7.15%
ROIC/WACC1.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A